Research News Bar 2

TREAT ALS Builds on Concrete Research Progress by The ALS Association

Treat ALS Logo

The ALS Association (ALSA) is committed to funding a diverse portfolio of research. A willingness to take risks brings researchers down new avenues. Some may prove to be dead ends. But all the routes to discovery explored in the past decade have produced evident progress in our understanding of the disease, progress that deserves to be brought rapidly into the clinic. ALSA has therefore launched a major new initiative to prioritize and bring promising compounds into clinical trials in a focused approach called Translational Research Advancing Therapy for ALS, or TREAT ALS.

>>Read full story


Clinical Research Pilot Study Request for Proposals

RELEASE DATE:  July 1, 2005

Deadline for brief study outline: July 15, 2005

>> View details


Treatment Targets for ALS Identified in Cell Based Screening Tests

[QUICK SUMMARY: ALSA funded researchers have published information gathered by screening existing drugs in cell based tests that suggest possible avenues towards new ALS treatments.]

>>Read full story





 ALS Research Overview
Read ALSA's White Paper on the State of ALS Research.
 Meet ALSA's Science  Director & VP
Read the interview with ALSA's Science Director Lucie Bruijn, PhD.
 ALSOD Database
Visit the online database for ALS/SOD1 genetic mutations at http://www.alsod.org/